Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Qilu Stem Cell Engineering Co., Ltd. is a leading Chinese biotechnology company specializing in the collection, preservation, and clinical application of stem cells. Established as a joint venture involving the Yinfeng Biological Group, the company operates the Shandong Provincial Cord Blood Bank, one of the oldest and largest cord blood storage facilities in China. Beyond storage, the company is heavily involved in regenerative medicine research, developing cell-based therapies for hematological malignancies, immune system disorders, and degenerative conditions. Their facilities include large-scale GMP-compliant laboratories dedicated to the expansion and quality control of various cell types, including mesenchymal stem cells and immune cells.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Qilu Stem Cell.